Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L King

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
NPJ Vaccines|April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop reportJane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
NPJ Vaccines|April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop reportJane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Pageof 3